Company Description

Mendel is a hybrid intelligent engine (human/AI) that can collect a patient’s medical records and combine it with the genetic profile of his or her cancer to find personalized meds that are still in the trial phase. It can also pair a patient with oncologists with a track record matching the patient’s case for a second opinion. Mendel’s business model is free for patients, including the 56% of cancer patients outside the U.S. and Europe.